Sotac Pharmaceuticals Dividend
The Dividend of Sotac Pharmaceuticals (SOTAC.NS) as of Oct 25, 2026 is 0.10 INR.
Get this data via API
Financial Data API
Dividend
0.10INR
Dividend yield
0.11 %
Last updated:
How much dividend does Sotac Pharmaceuticals 2026 pay?
According to the latest status from October 2026, Sotac Pharmaceuticals paid a total of 0.10 INR per share in dividends within the last 12 months. With the current Sotac Pharmaceuticals price of 92.00 INR, this corresponds to a dividend yield of - %. A dividend is paid times per year.
At today's price the dividend yield works out to roughly 0.11%. The payout ratio is around 1% of earnings.
Historical Sotac Pharmaceuticals Dividends
A dividend is paid times per year. Last year, the payout months were and October.
| Paydate | Dividend |
|---|---|
| 0.10INR |
The Sotac Pharmaceuticals Dividend history
3 Years
10 Years
25 Years
Max
| YEAR | Dividend | YoY |
|---|---|---|
| 0.10INR | — | |
| 0.00INR | — | |
| 0.00INR | — | |
| 0.00INR | — | |
| 0.00INR | — | |
| 0.00INR | — |
Sotac Pharmaceuticals dividend history and estimates
Max
Details
Is the Sotac Pharmaceuticals Dividend Safe?
Sotac Pharmaceuticals has been increasing the dividend for 0 years.
Analysts expect a Dividend Cut of -100.00% for the current fiscal year.
Sotac Pharmaceuticals dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Dividend Details
Understanding Sotac Pharmaceuticals's Dividend Distributions
Sotac Pharmaceuticals’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Sotac Pharmaceuticals's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Sotac Pharmaceuticals's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Sotac Pharmaceuticals’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Sotac Pharmaceuticals Stock analysis
Frequently Asked Questions about Sotac Pharmaceuticals stock
The current dividend yield of Sotac Pharmaceuticals is 0.11 %.
Sotac Pharmaceuticals paid dividends every year for the past 1 years.
Sotac Pharmaceuticals is assigned to the 'Health' sector.
To receive the latest dividend of Sotac Pharmaceuticals from 10/29/2025 amounting to 0.1 INR, you needed to have the stock in your portfolio before the ex-date on 9/19/2025.
The last dividend was paid out on 10/29/2025.
In the year 2025, Sotac Pharmaceuticals distributed 0.1 INR as dividends.
The dividends of Sotac Pharmaceuticals are distributed in INR.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
All Key Metrics — Sotac Pharmaceuticals
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth